Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

Dr. Michael Weber brings expertise in spine oncologic surgery to UConn Health Dr. Michael Weber is an internationally ...

Data are from the largest multi-institutional study on robotic-assisted radical cystectomy (RARC) with totally intracorporeal neobladder urinary diversion.

John Burke, MD, discusses his editor-in-chief column from the July 2025 issue of Targeted Therapies in Oncology.

Discover the transformative impact of robotic-assisted surgery (RAS) on patient care and recovery times in India, as leading ...

ETHealthworld.com brings latest intuitive surgical news, views and updates from all top sources for the Indian Health industry.

(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration has extended the review period for Blenrep combinations in relapsed/refractory multiple myeloma after an advisory ...

The FDA cited trial design concerns and lack of substantial evidence in denying approval for Replimune’s biologics license application in advanced melanoma.

Investigators compared early oncologic outcomes by staging modality among men diagnosed with very high-risk prostate cancer.

Glofitamab is a bispecific CD20-directed CD3 T-cell engager approved under the brand name Columvi ® for the treatment of adults with R/R DLBCL, not otherwise specified or large B-cell lymphoma arising ...

Roche and Genentech were unable to sufficiently demonstrate the benefit of using Columvi in an earlier treatment setting for ...

Most Oncologic Drugs Advisory Committee members took issue with the lack of dosing optimization and the lack of US patient ...